ZANIDIP is indicated for the treatment of mild to moderate essential hypertension. Some individuals, not adequately controlled on a single antihypertensive agent may benefit from the addition of ZANIDIP with beta-adrenoceptor blocking drug, a diuretic or an angiotensin-converting enzyme inhibitor.